Thor Ostenfeld Email
Senior Medical Director @ MoonLake Immunotherapeutics (NASDAQ: MLTX)
5 free lookup(s). No credit card required.
If you need more lookups,
subscriptions start at $34 USD/month.
Thor Ostenfeld Location
- United Kingdom
Thor Ostenfeld Work
- 2025 -now Senior Medical Director @
- 2023 -2024 Head Clinical Development and Global Clinical Lead RTX @
- 2018 -2022 Head Clinical Development, Neurosciences @
- 2004 -2022 Consultant Anaesthetist @
- 2015 -2018 Senior Medical Director Neurosciences @
- 2012 -2015 Director Clinical Development, Immuno-Inflammation and Kinase DPU @
- 2010 -2012 Director Experimental Medicine, EU Centre of Excellence for External Drug Discovery (CEEDD) @
- 2006 -2010 Director Discovery Medicine, Neurosciences Centre of Excellence for Drug Discovery @
- 2004 -2006 Discovery Clinical Development Physician, Neurology Centre of Excellence for Drug Discovery @
Thor Ostenfeld Education
- Imperial Business School
MBA
- University of Dundee
BSc (Pharmacology)
- University of Cambridge
PhD (Brain Repair)
- University of Dundee
MBChB (Medical School)
Thor Ostenfeld Skills
- Public Speaking
- Sales
- Strategic Planning
- Clinical Research
- Infectious Diseases
- Lifesciences
- CRO Management
- Clinical Trials
- Biotechnology
- Drug Development
- Clinical Development
- Life Sciences
- Drug Discovery
Thor Ostenfeld Summary
- Thor Ostenfeld, based in United Kingdom, is currently a Senior Medical Director at MoonLake Immunotherapeutics (NASDAQ: MLTX). Thor Ostenfeld brings experience from previous roles at Grünenthal Group, AstraZeneca, Cambridge University Hospitals NHS Foundation Trust and MedImmune. Thor Ostenfeld holds a MBA @ Imperial Business School. With a robust skill set that includes Public Speaking, Sales, Strategic Planning, Clinical Research, Infectious Diseases and more. Thor Ostenfeld has 1 emails on RocketReach.
Looking for a different Thor Ostenfeld?
Find contact details for 700 million professionals.
G2 Crowd Trusted
300K+ Plugin Users
© 2026 RocketReach.co